Ketryx raises $39M to advance AI compliance in life sciences
Table of Contents
Austrian-American Ketryx, the AI-powered compliance platform helping life sciences companies ship safer products faster, today announced a $39 million Series B, bringing the company’s total funding to over $55 million.
Life sciences teams face the challenge of balancing strict compliance requirements with the accelerating pace of innovation. Despite advances in cloud tools and LLMs, most still rely on infrastructure not built for this speed of change.
Ketryx addresses this gap by automating validation, traceability, and regulatory workflows, including FDA and EU MDR-ready documentation, across the product development lifecycle. The result is safer products delivered faster, with customers reporting up to 90 per cent less documentation time and release cycles more than 10 times quicker.
